ATRC vs ZBH · rev $294.9M vs P/E 23, rev $4.26B
AtriCure Inc (ATRC) versus Zimmer Biomet Holdings Inc (ZBH) — a side-by-side from cached financials, not a winner call.
AtriCure Inc (ATRC) is a medical instruments & supplies company listed on US.
Zimmer Biomet Holdings Inc (ZBH) is a medical devices company listed on NYSE.
Latest reported ATRC revenue for 2026-06-30 was $294.9M. Net income was $9.1M. ATRC currently screens at market cap $1.37B.
Latest reported ZBH revenue for 2026-06-30 was $4.26B. Net income was $436.5M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
ATRC currently screens at market cap $1.37B. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
Not investment advice. Open the ATRC and ZBH stock pages for the full models.
Not investment advice.